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Abstract: 
This quasi-experimental study investigated the efficacy of clinic-based advocacy for intimate 
partner violence (IPV) to increase help seeking, reduce violence, and improve women’s well-
being. Eligible and consenting women attending one of six selected clinics in the rural Southern 
United States were assessed for IPV. Consenting women disclosing IPV were offered either an 
in-clinic advocate intervention or usual care, depending on the clinic they attended and were 
followed for up to 24 months. Over follow-up time both IPV scores and depressive symptoms 
trended toward greater decline among women in the advocate intervention clinics relative to the 
usual care (business card referral only). 
Keywords: abuse | depression | evaluation | health care | intervention | women | intimate partner 
violence 
Article: 
Introduction 
Intimate partner violence (IPV) is a health threat that meets most of the disease-specific 
requirements for screening (Cole, 2000). IPV is common (lifetime prevalence of at least 25%) 
and has significant consequences, including depression, posttraumatic stress disorder (PTSD), 
substance abuse, and homicide or suicide (Bonomi et al., 2006; Campbell, 2002; Campbell & 
Lewandowski, 1997; Plichta, 2004). Valid screening tools exist to identify victims of IPV 
(Brown, Lent, Schmidt, & Sas, 2000; Coker, Pope, Smith, Sanderson, & Hussey, 2001; Feldhaus 
et al., 1997;McFarlane, Parker, Soeken, & Bullock, 1992; Sherin, Sinacore, Li, Zitter, & Shakil, 
1998) A growing literature indicates that screening is feasible in busy clinic settings (Coker et 
al., 2007) and that screening is acceptable to the majority of women (Arias, Lynberg, Simon, 
Kresnow, & Shelley, 2004). 
A remaining question to be answered before the health care community universally implements 
IPV screening is whether effective clinic-based interventions exist to reduce the health threat 
posed by IPV. Advocacy and counseling are common components of shelter services that have 
been used for decades, yet few trials have evaluated the short- and longer-term efficacy of such 
interventions. Although many clinics and hospitals have services in place for IPV survivors, few 
prospective intervention trials have evaluated the efficacy of such interventions to improve 
health and safety for women. Two such trials in prenatal (McFarlane, Soeken, & Wiist, 2000) 
and primary care (McFarlane, Groff, O’Brien, & Watson, 2006 ) settings found that although 
IPV scores declined over time for up to 24 months among those screened, scores did not differ 
by two interventions implemented: Giving a wallet-sized card with local services described or 
individualized counseling and safety planning. In contrast, a large (N = 1,044) randomized 
controlled trial of pregnant women experiencing IPV reported that women randomized to a 
individually tailored counseling intervention were less likely to experience recurrent IPV during 
pregnancy or postpartum and the intervention was associated with a reduction in preterm births 
(Kiely, El-Mohandes, El-Khorazaty, & Gantz, 2010). A small randomized clinical trial 
conducted in urban Chinese community clinics found that an intensive advocate intervention 
reduced depressive symptoms in the short yet not in the longer term when compared with those 
receiving usual community referrals (Tiwari et al., 2010). 
Here we report on the efficacy of an in-clinic IPV advocacy intervention on help seeking, IPV 
continuation, and physical and mental well-being. All clinics in the study conducted IPV 
assessments. Some clinics (usual care) provided referrals to external IPV agencies for women 
who were assessed as positive for IPV; others had an IPV advocate onsite for immediate, face-to-
face counseling and support for women who were assessed as positive for IPV. We hypothesized 
that the in-clinic IPV advocate would increase a range of help-seeking behaviors and over time 
reduce violence experienced. Furthermore, relative to the control clinics, those in the advocate 
intervention clinics were hypothesized to have fewer depressive symptoms, including suicidal 
ideation, fewer medical care visits, and better self-perceived physical and mental health over 
time. 
Methods 
Selection of Participating Clinics 
The current study employed a quasi-experimental design to evaluate the efficacy of having an 
IPV advocate in the clinic for immediate consult following a positive IPV assessment compared 
to the usual practice of referring women to an external IPV advocacy agency. Randomization of 
the intervention was done at the clinic level rather than the individual level. All clinics were 
located in the service region of the Pee Dee Coalition Against Domestic Violence and Sexual 
Assault (hereafter “the coalition”). Clinics were recruited to participate if they (a) were located in 
the referral range of the coalition, (b) provided primary care to lower-income women, (c) had a 
patient volume of at least 1,000 women per year, and (d) were willing to participate. Clinics were 
allocated to the in-clinic advocate intervention versus the usual care such that there would be 
similar numbers of patients in the intervention and usual care groups. 
After intervention allocation, the staff at each clinic were oriented and trained by the project 
manager and principal investigator according to the specific intervention allocated to their clinic. 
This training included general education on IPV, instruction on how to conduct and score the 
assessment tool, and instruction regarding how to make referrals for women who screen as IPV 
positive (Smith, Danis, & Helmick, 1998). To maintain high screening and referral rates, the 
project manager met with nursing staff at the clinics on a monthly basis to review clinic-specific 
assessment rates and to discuss any problems with study implementation. 
IPV Assessment 
The process for IPV assessment has been described in detail elsewhere (Coker et al., 2007). 
Briefly, nurses described the study to eligible women. Eligibility was defined based on age 18 or 
older, in an intimate relationship in the past 5 years, and mentally competent to provide consent. 
Consenting women were first asked to think about their current male partner or their most recent 
male partner if they did not have a current partner. Partner was defined as “someone you have 
been married to, dated, or had a sexual relationship with.” Women were then asked a series of 
questions assessing psychological battering using a modified version of the Women’s Experience 
With Battering Scale (WEB; Smith, Earp, & DeVellis, 1995; Smith, Smith, & Earp, 1999;Smith, 
Tessaro, & Earp, 1995). The following question from CDC’s Behavioral Risk Factor 
Surveillance System (BRFSS) was used to assess both physically and sexually violent acts by a 
partner (current or recent): “Has any partner been physically violent toward you? By violent, I 
mean did he punch, kick, hit, shove, slap, choke or physically attack you in other ways that could 
result in an injury. It also means being made to do sexual acts when you don’t want to.” Finally, 
women were asked about psychological and physical abuse by any partner in the past 5 years. 
Women who were accompanied by others during their clinic visit who did not leave the room 
were not assessed for safety reasons. The charts for these women were flagged and nurses 
attempted assessment on a subsequent visit. Nurses asked the assessment questions of consenting 
women because of generally low reading levels. 
The assessment results for each woman were coded as either IPV positive (IPV+) or IPV 
negative (IPV–). Women who were assessed as positive for any form of IPV within the past 5 
years were offered the advocate intervention in the intervention clinics or external referral in the 
usual care clinics. Based on these results, women who were assessed as IPV+ could be 
distinguished as either currently in an abusive relationship (hereafter “current”) or in an abusive 
relationship within the past 5 years (hereafter “recent”). 
Nurses also invited women to participate in a follow-up study to evaluate the effectiveness of an 
intervention study for women who were assessed as IPV+. Women were told that they would be 
interviewed every 6 months for up to 24 months. Women with an interest in the study were 
contacted within 2 weeks of the initial IPV assessment by trained research staff for the baseline 
interview. This contact was made primarily by phone, using one of the safe phone numbers 
women provided. If there was no safe phone number, women were contacted for interviews at 
their next clinic appointment. Informed consent was obtained after staff explained the 
procedures, risks, and benefits to the follow-up study. Written consent for assessment and 
subsequent interviews was obtained. The Institutional Review Boards of the University of South 
Carolina, the University of Texas Health Science Center, and the Centers for Disease Control 
and Prevention approved this protocol. 
Description of the Interventions 
Usual care 
In the “usual care” (or comparison) arm, women who were assessed as IPV+ were given the 
business card of their health care provider with the coalition hotline number. 
Clinic-based IPV advocate 
All women who were assessed as IPV+ in clinics allocated to the intervention were encouraged 
by the nurse to meet with the advocate immediately after their appointment. Women who had 
limited time for their visits were encouraged to meet briefly with the advocate to make an 
appointment for a subsequent visit. The advocate was available during clinic hours to provide 
needs assessment, safety planning, education, support, and referral/facilitated linkage to coalition 
services and other community services the woman may need. Project funds covered the salaries 
for two clinic-based IPV advocates. To protect confidentiality, women did not pass through any 
public areas on the way to the advocate’s private office. Furthermore, the nurse introduced the 
patient to the advocate using a first name. Women in the intervention arm also received the 
business card of their health care provider with the coalition hotline number. 
Evaluation Plan 
To evaluate the impact of the advocate intervention on women’s selected outcomes, including 
help-seeking behaviors and continued IPV, women who were assessed as IPV+ were invited into 
a longitudinal cohort study to prospectively assess these outcomes. Our analysis was based on 
self-report of outcomes over time. We conducted an intent-to-treat analysis in which outcomes 
were assessed independent of whether women receiving care in clinics with the advocate 
intervention actually talked with an advocate at any time during follow-up. Women receiving 
care in the usual care clinics were the comparison group. 
Outcome Measures Used 
We hypothesized that relative to IPV+ women in usual care clinics, IPV+ women in the advocate 
intervention clinics would have increased help seeking in the short term, decreased violence 
scores, decreased depressive symptom scores, fewer medical care visits, and greater 
improvements in self-perceived physical and mental well-being all in the longer term. 
We expanded the help-seeking questions used in the National Violence Against Women Survey 
(NVAWS; Tjaden & Thoennes, 1998) and made the items specific to those services provided in 
the study area. The help-seeking score included 17 (current sample Cronbach’s α = .73, range 0-
44) questions on disclosure of partner violence and specific forms of help seeking by the 
following domains: (a) law enforcement/legal assistance (4 items), (b) community services for 
abused women (7 items), (c) mental health counseling (2 items), (d) talking with a health care 
provider about partner violence in a clinic or health department (2 items), and (e) disclosure to 
family and friends (2 items). For each item women were asked whether or not they sought help. 
If so, the frequency of help seeking was recorded with a response ranging from never(coded 0) 
to more than 20 times (coded 5). 
We measured continued IPV and victim safety using the 17-item Danger Assessment Score 
(DAS; Campbell, 1995; Cronbach’s α = .91) and the WEB (Smith et al., 1999,1995). Reduced 
response options (agree/disagree) were used from the original 10 items of the WEB Scale 
(Cronbach’s α = .93). The Danger Assessment was designed to evaluate risk of homicide by an 
abusive partner and includes questions regarding partner gun ownership, unemployment, 
substance use, threats to kill women and/or children, threats of suicide, past arrests for violence, 
physical abuse, forced sex, attempted strangulation, controlling and stalking behaviors, extreme 
jealousy (“If I can’t have you, no one can”), and whether the woman believes her partner is 
capable of killing her. The WEB Scale (using 10 statements) measures how some women feel in 
battering relationships. Example statements include, “My partner makes me feel unsafe even in 
my own home,” “I feel ashamed of the things my partner does to me,” and “I feel owned and 
controlled by my partner.” The WEB does not directly measure current physical abuse; however, 
in combination with the DAS, these scales provide a measure of both physical and psychological 
abuse. 
Five items from the Medical Outcomes Study (Ware, Snow, Kosinski, & Gandek, 1997) were 
used to measure a woman’s perception of her own physical and mental health relative to others 
of her own age. Response options ranged from excellent topoor with higher scores indicating 
poor health. Two items queried how much (a) mental, or (b) physical health interfered with a 
woman’s daily activities over the past month; response options ranged from not at 
all to extremely, with higher scores indicating greater interference. One item addressed how 
much physical pain women experienced in the past month; response options ranged 
from none to very severe, with higher scores indicating greater pain. Two items adapted from the 
CDC BRFSS were used to measure current (past 6 months) symptoms of depression and suicidal 
ideation as dichotomous variables (Nelson, Holtzman, Bolen, Stanwyck, & Mack, 2001). The 
two items were as follows: “In the past six months, have you seriouslyconsidered attempting 
suicide?” And, “In the past six months, have you ever had a period of two weeks or longer when 
you were feeling depressed or down most of the day or nearly every day?” Four items were used 
to measure the number of medical care visits women had received in the past 6 months in terms 
of physician visits, emergency room visits, being hospitalized, and having a new medical 
diagnosis. 
Statistical Analysis 
All analyses were conducted via PROC MIXED in SAS version 9.2. Linear mixed model 
(LMM) regression analysis was used to control for the nesting of effects of the intervention 
within clinics and correlated repeated measures by respondents over time. Analyses were 
restricted to those with at least two visits/interviews over time for up to 24 months of follow-up. 
The LMM is more flexible than the general linear model (GLM) because it does not require an 
equal number of repeated measurements for all subjects. Specifically, PROC MIXED offers a 
wide variety of covariance structures that allowed us to account for differences in follow-up time 
points. Follow-up measurements that were collected closer in time are assumed to be more 
correlated than measurements that were taken further apart. Thus, all timed outcome data, even 
for participants with some missing repeated measurements, were utilized for parameter 
estimation. Models were adjusted at baseline by whether the IPV was “current” or “recent” since 
the timing of IPV influences help seeking by domain as well as self-perceived mental and 
physical health. Those experiencing current IPV at baseline may be more likely to benefit from 
the intervention; therefore, we repeated this analysis testing for an interaction of intervention, 
time, and current IPV+ at baseline. Means are adjusted for age, current IPV status, number of 
interviews, and baseline outcome measures. 
Results 
Table 1 presents the response rates for IPV assessment and entrance into the cohort study with 
interviews through 24 months. Among eligible women, 26% refused IPV assessment. 
Approximately 25.6% of eligible and assessed women were IPV+. Among the screened women 
who had experienced IPV in the past 5 years, 429 (46%) agreed to follow-up contact. Within this 
group, 76% or 327 completed the baseline interview and 231 (70.6%) completed at least one 
follow-up interview. Of women who completed at least one follow-up interview after the 
baseline interview (n = 231), 75% completed a 6-month interview, 60% completed a 12-month 
interview, 50% completed an 18-month interview, and 30% completed a 24-month interview. 
Table 1. Response Rates for Assessment and Follow-Up Rates Through 24 Months 
Screening and follow-up  Number  Percent 
Invited to IPV (intimate 
partner violence) assessment  
5,683  100.0 
Ineligible  −738  −12.6 
Refused (of 4,945 eligible)  −1,281  −26.0 
Eligible and assessed  3,664  74.0 
IPV+a  939  25.6 
Agreed to follow-up study  429  46.0 
Completed baseline interview  327  76.0b 
Completed at least one follow-
up interview  
231  70.6c 
aOnly IPV+ women were invited into follow-up study bOf those consenting to follow-up contact 
for cohort. cOf those completing a baseline interview. 
To evaluate whether the quasi-experimental design resulted in a similar distribution of potential 
confounders by intervention arm, the demographic profile and timing of IPV were compared by 
intervention arm for women who completed at least one follow-up survey (Table 2). Women 
attending clinics in the intervention arm were significantly older. The two groups did not differ 
significantly in terms of race, education, marital status, number of children, number in the 
household, or the proportion currently experiencing IPV (all p values > .05). Because the average 
age differed by intervention arm, all subsequent analyses were adjusted for age and number of 
interviews over time. 
Table 2. Baseline Comparisons of the In-Clinic Intimate Partner Violence (IPV) Advocate 
Intervention Versus Usual Care (Control) Group by Demographic Variables, Current IPV+ 
Status, and Contact With an Advocate or Coalition Services 
 IPV advocate 
(intervention) 
 Usual care (control)  Differences by 
intervention 
Demographic factors  n = 138  n = 93  t test, chi-square (p 
value) 
Age: M ± SE  42.62 (0.90)  38.08 (1.10)  t = 3.16 (0.002) 
Race: % African 
American  
68.8%  55.9%  χ2 = 3.99 (0.06) 
Education: % < high 
school graduate  
31.4%  34.4%  χ2 = 0.229 (0.63) 
Marital status: % 
currently divorced or 
separated 
 22.5%  22.6%  χ2 = 0.01 (0.99) 
Number of children: 
M ± SE  
2.09 (0.15)  2.19 (0.18)  t = 0.41 (0.68) 
Number of household 
members: M ± SE 
 2.96 (0.15)  3.27 (0.18)  t = 1.35 (0.18) 
Current versus recent 
IPV+ % experiencing 
IPV by a current 
partner 
 46.4%  47.3%  χ2 = 0.019 (0.89) 
Contact with advocate or coalition services 
% talked to advocate 
in clinica 
 32.8%  4.4%  χ2 = 26.00 (<0.0001) 
% called coalition 
hotlineb 
 21.4%  17.4%  χ2 = 0.63 (0.43) 
Note. M = Mean; SE = standard error. aPossible result of the intervention. bPossible result of 
usual care (control). 
A greater proportion of women receiving care in the advocate intervention clinics reported 
talking with an advocate in their clinic (32.8%), relative to women in the usual care arm 
(4.4%; Table 2). Note that although advocates were not present in person in the usual care 
clinics, women could talk with an advocate at the PDC. Although women in both arms were 
offered a card with the coalition hotline number, there were no differences in the proportion of 
women in the intervention or usual care who called the coalition hotline. 
Outcome Evaluation 
Adjusted means scores and standard errors are presented in Table 3 along with the Fstatistic 
and p value for the main Intervention effect, the Time effect, and the Intervention × Time 
interaction. The latter is the critical test of whether there was differential change by intervention 
group over time. Although it is not shown in Table 3, we additionally ran the Intervention × 
Time interaction among women who were currently experiencing IPV, in order to explore the 
effect of current IPV on the range of outcomes. 
Table 3. Test of the Intervention Effect on Hypothesized Outcomes Over Follow-Up: Linear 
Mixed-Model Regression Analysis Comparing Means Score for the Intervention and Control 
Arms Among Those With At Least Two Visits up to 24 Months’ Follow-Up 
 Adjusteda means (standard 
error) by intervention arm  
F (p value) 
Outcome  Intervention 
(n = 447)b 
Control (n = 
304)b  
Intervention  Time Intervention 
× Time 
Help-seeking activity in the prior 6 months 
Any interactions 
with advocate 
(yes/no)c 
0.18 (0.03)  0.01 (0.04)  11.29 (0.001)  4.67 (<.001)  3.70 (0.003) 
Number of 
interactions with 
all help-seeking 
sourcesc 
9.11 (0.84)  10.17 (1.19)  0.52 (0.47)  54.09 
(<.001)  
0.36 (0.87) 
Number of calls to 
coalition hotline 
calls 
0.10 (0.06)  0.11 (0.10)  0.02 (0.90)  10.03 
(<.001)  
0.12 (0.99) 
Number of times 
called police, 
involved lawyers 
for receiving 
protective order 
0.90 (0.21)  0.96 (0.34)  0.03 (0.87)  35.26 
(<.001)  
2.10 (0.06) 
Number of times 
talked with 
physician about 
IPV (intimate 
partner violence) 
0.63 (0.10)  0.83 (0.12)  1.55 (0.21)  40.90 
(<.001)  
0.00 (0.98) 
Number of times 
talked with family 
or friends about 
IPV 
4.84 (0.42)  5.30 (0.65)  0.34 (0.56)  23.96 
(<.001)  
0.24 (0.94) 
IPV measures 
Women’s 
Experience With 
Battering (WEB) 
Scale score 
21.61 (1.67)  26.50 (2.36)  2.82 (0.10)  5.22 (<.001)  1.79 (0.11) 
Danger 
Assessment Scale 
(DAS) score 
0.66 (0.20)  0.65 (0.28)  0.00 (0.97)  8.34 (<.001)  2.02 (0.07) 
Mental Health Outcomes  
Rating of current 
mental/emotional 
health 
3.45 (0.09)  3.40 (0.13)  0.12 (0.73)  0.85 (0.52)  1.29 (0.26) 
Interference of 
mental health with 
daily activities, 
past month 
2.48 (0.11)  2.08 (0.15)  4.50 (0.04)  0.34 (0.89)  0.85 (0.51) 
Depression/suicide 
ideation symptom 
score 
1.35 (0.09)  1.41 (0.12)  0.13 (0.72)  4.32 (<.001)  3.10 (0.01) 
Rating of current 
physical health  
3.79 (0.10)  3.44 (0.14)  4.09 (0.04)  1.86 (0.10)  0.41 (0.84) 
Interference of 
physical health 
with daily 
activities past 
month 
2.60 (0.12)  2.28 (0.16)  2.59 (0.11)  3.15 (0.01)  1.54 (0.18) 
Amount of 
physical pain, past 
month 
3.81 (0.12)  3.70 (0.17)  0.34 (0.56)  2.48 (0.03)  1.59 (0.16) 
Number of medical care visits (past 6 months) 
Number of 
physician visits  
3.76 (0.39)  4.81 (0.57)  2.32 (0.13)  2.29 (0.04)  0.95 (0.45) 
Number of 
emergency 
department visits  
0.84 (0.13)  0.76 (0.20)  0.13 (0.72)  2.06 (0.07)  0.30 (0.91) 
Number of 
hospitalizations  
0.23 (0.06)  0.33 (0.09)  0.81 (0.37)  1.99 (0.08)  1.35 (0.24) 
aMeans are adjusted for age, current IPV status, number of interviews. bn = Woman × Interview. 
cCalled/involved police, lawyer, family/friends, physicians or nurses, and PDC advocate and 
PDC services (hotline, shelter, counseling, groups). 
Women in the advocate intervention arm were significantly more likely to use services provided 
by the advocate (Table 3; p = .003), and this increased use was most likely to occur (p < .05) 
early in the intervention (first 6 months; not reported in Table 3). Women attending clinics with 
the advocate intervention were more likely to report involving police, lawyer, or court systems to 
receive protective orders (legal/law enforcement help seeking), relative to women attending 
clinics not randomized to the advocate intervention. Women attending clinics with the advocate 
intervention did not differ from those in usual care clinics in any other help-seeking domain. It is 
important to note that only 33% of IPV+ women receiving care in clinics with an advocate 
reported talking with an advocate on their first screening visit and enrollment clinic, and only 
14% of women in these intervention clinics talked with an advocate on a subsequent visit over 
follow-up (not reported in Table 3). 
In general, IPV scores (DAS, WEB) were highest during the first interview and declined over 
time (not reported in Table 3). IPV scores in the advocate intervention clinics trended toward 
greater decline over time relative to usual care (i.e., Intervention × Time interaction for DAS 
scores, F = 2.02, p = .07). A reduction in DAS scores associated with the advocate intervention 
was more likely to occur within the first 6 months of the intervention and among those women 
experiencing current IPV at baseline (p < .05; not reported in Table 3). A similar pattern was 
observed for WEB Scale score over time. 
No differences were observed in either self-perceived current mental health or interference of 
mental health on daily activities between the intervention and the usual care arms. However, 
scores for depressive symptoms and suicidal ideation were significantly lower over time for 
IPV+ women in the intervention clinics relative to the usual care arms (Table 3). No differences 
in self-perceived physical health, interference, or physical pain were noted when comparing the 
intervention and usual care clinics over time (Table 3). 
Although the adjusted mean number of medical care visits were lower over time among those in 
the intervention clinics relative to the usual care visits, these differences were not statistically 
significant (Intervention × Time; see Table 3). 
Discussion 
Results from this quasi-experimental study indicate that referring IPV+ women to an in-clinic 
IPV advocate reduces violence as well as depressive symptoms yet does not affect help-seeking 
behaviors (beyond the IPV advocate contact) or the frequency of receiving medical care relative 
to those receiving usual care. 
Help seeking was high at the baseline interview. Almost 90% of women reported either formal 
(police or other legal = 57%, coalition = 45%, or medical = 36% or mental health services = 
46%) or informal help seeking from friends or family (84%). This may be a function of the 
intervention because women were interviewed after they had been assessed for IPV and after 
they had the opportunity to meet with the advocate in the clinic. Although interviewers instructed 
respondents to include help seeking only for the prior 6-month period and not include help 
seeking directly resulting from the recent clinic visit, some women may have included 
intervention-associated help seeking within the first 6-month time frame. As noted, few studies 
have evaluated the efficacy of clinic-based interventions to improve health and safety for women 
experiencing IPV. Several published intervention studies are somewhat comparable with the 
current study, yet each differed in terms of the population setting or intervention used (Cripe et 
al., 2010; McFarlane et al., 2006, 2002, 2000; Sullivan & Bybee, 1999; Tiwari et al., 2010). 
Similar to others we noted that IPV scores declined over time among both the intervention and 
usual care interventions (McFarlane et al., 2006, 2000). Like Tiwari et al., yet in contrast with 
others (Cripe et al., 2010; Gillum, Sun, & Woods, 2009;McFarlane et al., 2006, 2002, 2000), we 
observed a reduction in depressive symptoms over time in the advocate intervention clinics 
relative to a usual care condition. Our findings regarding a reduction in IPV scores over time 
among women in the advocate intervention clinics was consistent with a large study in an urban 
and pregnant population (Kiely et al., 2010) yet contrasts with others (McFarlane et al., 
2006, 2002,2000; Tiwari et al., 2010). Other studies have evaluated similar in-clinic 
interventions to address the association between IPV or partner controlling behaviors and help-
seeking outcomes. Miller et al. (2011) observed that among women reporting IPV in a recent 
relationship (past 3 months; n = 156) those in the intervention arm that focused on in-clinic 
advocacy (n = 96) had a 71% reduction in the odds of pregnancy coercion compared with women 
in the control clinics (n = 60) over time. 
There are several important implications for IPV interventions in health care settings. First, the 
advocate intervention was significantly more effective relative to usual care in reducing IPV 
scores, particularly among women currently experiencing IPV. Second, advocate interventions 
also appear to reduce depressive symptoms relative to usual care over follow-up. 
Limitations of this work include a smaller sample for comparison in the later months of follow-
up. The bigger threat to validity is the potential for a selection bias. Our response rate for 
participation in the cohort study was less than 50%. It is difficult to recruit participants into a 
cohort study of 24 months duration, and this may be even more difficult among abused women. 
Women who may agree to and complete follow-up interviews differ from those who either do 
not volunteer or drop out. Given the complexity of the clinic settings, we were not able to 
randomize the individual to receive the IPV advocate intervention relative to the usual care arm. 
We addressed the possibility that individual clinic differences by intervention arm might explain 
study findings by our inclusion of the clustering of clinics within the treatment arms and by 
adjusting for demographic differences in the two groups. It is possible, however, that residual 
confounding may explain study findings as we were not able to adjust for multiple confounders 
given sample size limitations. 
Strengths of this study include the quality assurance of intervention implementation. On a 
monthly basis the project manager met with the nurses and advocates to (a) train new staff, (b) 
reinforce prior training on the usual care protocol for nurses, and (c) reinforce prior training for 
the advocates regarding rapport building, assessing immediate and long-term safety needs for 
patients, and making safety plans and referrals for desired legal, mental health, or advocacy 
services. The project manager also met individually with the advocates to debrief difficult cases 
and discuss alternate options for needed services. Due to confidentiality issues, the project 
manager did not directly observe private interactions with advocates and patients. 
This project’s results add to the existing literature in finding that the IPV advocate intervention 
was effective in reducing IPV scores and reducing depressive symptoms, including suicidal 
ideation, over follow-up. Because we found no differences in help seeking (with the exception of 
engaging an advocate in the clinic), it is unclear as to exactly why the onsite IPV advocate 
intervention affected WEB and DAS scores. It is possible that because the in-clinic advocates 
worked in the clinic on a full-time basis, abused women may not have viewed these women as 
“advocates” but as clinic staff. Women may have had contact with clinic-based advocates, but 
since they may have viewed these advocates as staff, some women may underreport actual 
contact with advocates. Our finding of a significant difference in reporting contact with clinic-
based advocates at baseline yet a more modest association across follow-up provides some 
support for this possibility. Perhaps simply being offered support from an IPV advocate in a 
familiar location such as a clinic, even without direct contact, served as a form of support to 
women in the onsite IPV advocate intervention. Although these results need to be replicated in 
other populations and with larger numbers of consenting participants, these data suggest that this 
relatively low-cost intervention of staffing clinics with a trained IPV advocate does reduce 
violence and depressive symptoms and may, therefore, improve safety as well as women’s well-
being. 
Our findings in combination with others (Kiely et al., 2010; Miller et al., 2011; Tiwari et al., 
2010) indicate that advocate interventions can have important implications for reducing violence 
and improving well-being over time. Our findings do not address the efficacy of screening as 
others have attempted (MacMillan et al., 2009). Rigorous research addressing the efficacy of 
screening alone for intimate and family violence is needed to address the U.S. Preventive 
Services Task Force recommendation (Nelson, Nygren, McInerney, & Klein, 2004). There is 
increasing evidence that clinic-based intervention improves health and safety outcomes for 
women experiencing IPV. 
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